Home > Insider Trading > Filing (0000919574-17-002069)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
835887	Progenics Pharmaceuticals Inc	PGNX	Pharmaceutical Preparations (2834)	133379479

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1511900	Ltd Fund Master Healthcare Broadfin	20 Genesis Close Ansbacher House, Second Floor, 1344 Grand Cayman E9 KY1-1108	No	No	Yes	No
1511901	Broadfin Capital, Llc	300 Park Avenue, 25Th Floor New York NY 10022	No	No	Yes	No
1601692	Kevin Kotler	C/O Broadfin Capital, Llc 300 Park Avenue, 25Th Floor New York NY 10022	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2017-02-13	100,000	$9.70	7,499,869	No	4	S	Direct
Common Stock	Disposition	2017-02-14	52,600	$9.70	7,447,269	No	4	S	Direct
Common Stock	Disposition	2017-02-14	50,000	$9.70	7,397,269	No	4	S	Direct
Common Stock	Disposition	2017-02-14	100,000	$9.70	7,297,269	No	4	S	Direct
Common Stock	Disposition	2017-02-14	150,000	$9.68	7,147,269	No	4	S	Direct
Common Stock	Disposition	2017-02-15	150,000	$9.55	6,997,269	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.